Robigo

Robigo is a biomanufacturing company developing a microbial platform technology that leverages bioengineering and data science to precisely protect crops from disease. The company's technology targets agricultural diseases while being safe for beneficial microbes, insect pollinators, human consumers, and the environment. Robigo's scalable platform utilizes naturally-occurring microbes, enhancing their ability to shield crops from diseases. The company initially focuses on developing solutions to address devastating diseases impacting high-value specialty crops for which few effective commercial treatments exist.

Robigo's approach aims to replace conventional pesticides, which are toxic to the soil, environment, and human consumers due to their indiscriminate killing mechanisms. Laboratory data demonstrated over a 90% reduction of diseases in multiple crops using Robigo's technology. The company secured USD 6.85 million in seed funding in February 2023 to demonstrate product efficacy in outdoor field environments and expand its platform capabilities to address a broader range of crops and diseases.